Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
Menses Phase01:18

Menses Phase

The uterine cycle begins with the menstrual phase, which is considered day one of the cycle and typically lasts about five days. This phase is characterized by the degeneration and shedding of the stratum functionalis, the functional layer of the endometrium.
When fertilization does not occur, the corpus luteum deteriorates, causing a significant drop in the levels of estrogen and progesterone in the body. This hormonal decrease triggers the release of prostaglandins, which cause the uterine...
Proliferative Phase01:20

Proliferative Phase

The proliferative phase typically occurs after menstruation and lasts between 6 to 13 days in a standard 28-day cycle. This phase involves the reconstruction of the endometrium, guided by estrogen produced by the developing ovarian follicle.
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of, and factors associated with, urogenital pelvic floor disorders among women from a refugee-background: A cross-sectional study.

Maturitasยท2026
Same author

Associations between testosterone and pre-androgens and sexual function; findings from the Australian Women's Midlife Years Study.

Fertility and sterilityยท2026
Same author

Symptom profiles in the late reproductive stage, earlier premenopause and early perimenopause in the absence of vasomotor symptoms: a cross-sectional study.

BMJ sexual & reproductive healthยท2026
Same author

By the First Session: Initial Evidence Regarding the Early Therapeutic Environment.

Psychotherapy and psychosomaticsยท2026
Same author

Food and Drug Administration, Menopause Hormone Therapies, and Black Box Warnings on Cardiovascular Disease: New Evidence or New Directions?

Circulation. Population health and outcomesยท2026
Same author

Transdermal testosterone gel vs placebo in women with diminished ovarian reserve prior to in vitro fertilization: a randomized, clinical trial.

Nature communicationsยท2026
Same journal

Occupational violence and staff safety in general practice.

Australian family physicianยท2018
Same journal

You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

Australian family physicianยท2018
Same journal

Understanding the decision to commence a dose administration aid.

Australian family physicianยท2018
Same journal

Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

Australian family physicianยท2018
Same journal

A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

Australian family physicianยท2018
Same journal

The Australian Mid-West Coastal Marine Wound Infections Study.

Australian family physicianยท2018
See all related articles

Related Experiment Video

Updated: Jun 1, 2026

Exploring Independent Effects of Follicle-Stimulating Hormone In Vivo in a Mouse Model
05:32

Exploring Independent Effects of Follicle-Stimulating Hormone In Vivo in a Mouse Model

Published on: August 11, 2023

Sex and perimenopause.

Susan R Davis1, Fiona Jane

  • 1School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria. susan.davis@monash.edu

Australian Family Physician
|May 21, 2011
PubMed
Summary
This summary is machine-generated.

Female sexual dysfunction, including low libido and painful sex, is common during perimenopause. Assessment should consider personal circumstances, with management ranging from discussion to therapeutic intervention.

More Related Videos

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

Related Experiment Videos

Last Updated: Jun 1, 2026

Exploring Independent Effects of Follicle-Stimulating Hormone In Vivo in a Mouse Model
05:32

Exploring Independent Effects of Follicle-Stimulating Hormone In Vivo in a Mouse Model

Published on: August 11, 2023

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

Area of Science:

  • Women's Health
  • Reproductive Endocrinology

Background:

  • Sexual difficulties are prevalent throughout a woman's life, particularly increasing during midlife and perimenopause.
  • Factors contributing to female sexual dysfunction include hormonal changes, relationship issues, psychological and physical wellbeing, and medication use (e.g., antidepressants).
  • Common sexual issues reported include dyspareunia, diminished desire, arousal difficulties, and challenges achieving orgasm.

Purpose of the Study:

  • To summarize female sexual dysfunction (FSD) in perimenopausal women.
  • To discuss advice general practitioners can offer.
  • To outline potential treatment options for FSD.

Main Methods:

  • Literature review and synthesis of current knowledge on FSD in perimenopausal women.
  • Discussion of clinical considerations for healthcare providers.
  • Overview of management strategies.

Main Results:

  • Female sexual dysfunction is multifaceted, influenced by biological, psychological, and social factors.
  • A comprehensive assessment is crucial, considering individual circumstances, partnership, sexual history, and cultural context.
  • Management approaches are varied, encompassing education, counseling, and medical interventions.

Conclusions:

  • Loss of libido, reduced desire, anorgasmia, and dyspareunia are common in late reproductive and perimenopausal years.
  • Holistic assessment is vital for effective management of FSD.
  • Treatment strategies should be individualized, ranging from informational discussions to advanced therapeutic interventions.